中文 | English
Return
Total: 6014 , 1/602
Show Home Prev Next End page: GO
Author:( Yu, LIANG)

1.Relationship between the level of plasma homocysteine and type 2 diabetes melltus patients with ischemic cerebrovascular disease

Liang YU ; Chuanqing YU

Chinese Journal of Primary Medicine and Pharmacy 2011;18(9):1178-1179

2. Determination of sufentanil in plasma of patients receiving intravenous combined anesthesia by LC-MS/MS

Yu LIANG

Chinese Pharmaceutical Journal 2012;47(2):146-149

3.Evaluation of Laboratory Testing Proj ect for Early Diagnosis of Neonatal Sepsis

Yu-jiang LIANG ;

Journal of Modern Laboratory Medicine 2014;(6):94-95,98

4.Detection and Identification of Amomum Viosum by Fluorescent Quantitative PCR

Yan YU ; Weiyang LIANG

China Pharmacist 2015;(6):946-948

5.THE DETECTION OF PROTEINURIA IN DIABETIC NEPHROPATHY AND ITS PATHOGENESIS

Yerong YU ; Jinzhong LIANG ;

Chinese Journal of Endocrinology and Metabolism 1986;0(04):-

6.The antibacterial activity of imipenem in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii

Liang YU ; Mei WANG

Chinese Journal of Infectious Diseases 2013;31(7):396-398

7.Therapentic effect of percutaneous balloon compression versus percutaneous radiofrequency thermocoagulation on idiopathic trigeminal neuralgia in aged patients

Liang YU ; Xiangming FANG

Chinese Journal of Geriatrics 2011;30(6):485-487

8.Effect of TRPM8 on proliferation and apoptosis of human bladder transitional cell carcinoma cell T24

Ping LIANG ; Lanfang YU

Journal of Chinese Physician 2015;17(10):1509-1512

9.The research, diagnosis, and treatment of thrombotic disease in China

Liang TANG ; Yu HU

Chinese Journal of Laboratory Medicine 2016;39(10):729-732

10.Retrospective Evaluation of Clinical Efficacy and Safety of Ticagrelor in the Patients with Acute Coronary Syndrome

Jing NA ; Yu LIANG

China Pharmacist 2017;20(3):494-497

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6014 , 1/602 Show Home Prev Next End page: GO